Showing results (81-90 of 496) with videos related to
Sort By:
Pageof 50
Pharmacogenomics|October 24, 2006
Pyrosequencing-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevanceMaren Rohrbacher, Anja Kirchhof, Gerd Geisslinger, et al.Nitric Oxide : Biology and Chemistry|March 7, 2003
Inhibition of cyclic guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulationAchim Schmidtko, Peter Ruth, Gerd Geisslinger, et al.Clinical Pharmacology and Therapeutics|August 2, 2003
Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory painMaria Burian, Irmgard Tegeder, Maic Seegel, et al.Anesthesiology|September 18, 2025
Topical Analgesics: Pharmacology and Clinical ApplicationsMarco Sisignano, Andrew S C Rice, Gerd GeisslingerBiochemical Pharmacology|May 9, 2002
Verapamil decreases glucuronidase activity in the gutJörn Lötsch, Bernhard Sperker, Heyo K Kroemer, et al.Journal of the National Cancer Institute|June 8, 2006
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsSabine Grösch, Thorsten Jürgen Maier, Susanne Schiffmann, et al.Pharmacology & Therapeutics|November 14, 2012
NOXious signaling in pain processingWiebke Kallenborn-Gerhardt, Katrin Schröder, Gerd Geisslinger, et al.International Journal of Molecular Sciences|February 26, 2022
Factors Determining Plasticity of Responses to DrugsMichael J Parnham, Jennifer A KrickerPlos One|December 24, 2011
Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injuryRuirui Lu, Wiebke Kallenborn-Gerhardt, Gerd Geisslinger, et al.Frontiers in Aging Neuroscience|May 16, 2022
The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the App Model of Alzheimer's DiseaseHendrik Nieraad, Natasja de Bruin, Olga Arne, et al.Pageof 50